Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study

Objective: We investigated the prevalence, evolution, associated factors, and risk factors of apathy in a cohort of patients with early-stage Parkinson's disease (PD), who underwent a 4-years prospective follow-up.Methods: This study included 188 patients with PD (baseline disease duration &...

Full description

Bibliographic Details
Main Authors: Ruwei Ou, Junyu Lin, Kuncheng Liu, Zheng Jiang, Qianqian Wei, Yanbing Hou, Lingyu Zhang, Bei Cao, Bi Zhao, Wei Song, Huifang Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.620762/full
id doaj-9d6212fe02064b3d9225cdac68eed3d6
record_format Article
spelling doaj-9d6212fe02064b3d9225cdac68eed3d62021-01-28T05:35:25ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-01-011210.3389/fnagi.2020.620762620762Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort StudyRuwei OuJunyu LinKuncheng LiuZheng JiangQianqian WeiYanbing HouLingyu ZhangBei CaoBi ZhaoWei SongHuifang ShangObjective: We investigated the prevalence, evolution, associated factors, and risk factors of apathy in a cohort of patients with early-stage Parkinson's disease (PD), who underwent a 4-years prospective follow-up.Methods: This study included 188 patients with PD (baseline disease duration <3 years) who underwent an annual evaluation using the Lille Apathy Rating Scale (LARS). Based on the cut-off value of −21 observed on the LARS, patients were categorized as PD with and without apathy. The generalized estimating equations (GEE) model was utilized to determine the factors associated with apathy, and the Cox proportional-hazards regression model was used to determine the predictors of apathy.Results: Apathy increased from a baseline rate of 18.6–28.8% after 4 years; notably, this rate was not persistent across patients' visits. The LARS score was independently associated with the male sex (B 8.131, p = 0.009), low Frontal Assessment Battery (FAB) scores (B 0.567, p = 0.011), low attention scores on the Montreal Cognitive Assessment (MOCA) test (B 0.217, p = 0.026), high Hamilton Depression Rating Scale (HDRS) scores (B 1.362, p < 0.001), high Unified Parkinson's Disease Rating Scale (UPDRS) part III scores (B 1.147, p < 0.001), and prolonged follow-up time (B 1.785, p = 0.048). A high HDRS score was the only predictor of apathy in PD [hazard ratio (HR) 1.043, p = 0.026].Conclusions: The risk of apathy is higher in men with progressive PD accompanied by disease-specific motor and non-motor symptoms. Depression during early-stage PD is a primary risk factor for apathy in PD.https://www.frontiersin.org/articles/10.3389/fnagi.2020.620762/fullParkinson's diseaseapathydepressionexecutive functioncohort study
collection DOAJ
language English
format Article
sources DOAJ
author Ruwei Ou
Junyu Lin
Kuncheng Liu
Zheng Jiang
Qianqian Wei
Yanbing Hou
Lingyu Zhang
Bei Cao
Bi Zhao
Wei Song
Huifang Shang
spellingShingle Ruwei Ou
Junyu Lin
Kuncheng Liu
Zheng Jiang
Qianqian Wei
Yanbing Hou
Lingyu Zhang
Bei Cao
Bi Zhao
Wei Song
Huifang Shang
Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
Frontiers in Aging Neuroscience
Parkinson's disease
apathy
depression
executive function
cohort study
author_facet Ruwei Ou
Junyu Lin
Kuncheng Liu
Zheng Jiang
Qianqian Wei
Yanbing Hou
Lingyu Zhang
Bei Cao
Bi Zhao
Wei Song
Huifang Shang
author_sort Ruwei Ou
title Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
title_short Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
title_full Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
title_fullStr Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
title_full_unstemmed Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study
title_sort evolution of apathy in early parkinson's disease: a 4-years prospective cohort study
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2021-01-01
description Objective: We investigated the prevalence, evolution, associated factors, and risk factors of apathy in a cohort of patients with early-stage Parkinson's disease (PD), who underwent a 4-years prospective follow-up.Methods: This study included 188 patients with PD (baseline disease duration <3 years) who underwent an annual evaluation using the Lille Apathy Rating Scale (LARS). Based on the cut-off value of −21 observed on the LARS, patients were categorized as PD with and without apathy. The generalized estimating equations (GEE) model was utilized to determine the factors associated with apathy, and the Cox proportional-hazards regression model was used to determine the predictors of apathy.Results: Apathy increased from a baseline rate of 18.6–28.8% after 4 years; notably, this rate was not persistent across patients' visits. The LARS score was independently associated with the male sex (B 8.131, p = 0.009), low Frontal Assessment Battery (FAB) scores (B 0.567, p = 0.011), low attention scores on the Montreal Cognitive Assessment (MOCA) test (B 0.217, p = 0.026), high Hamilton Depression Rating Scale (HDRS) scores (B 1.362, p < 0.001), high Unified Parkinson's Disease Rating Scale (UPDRS) part III scores (B 1.147, p < 0.001), and prolonged follow-up time (B 1.785, p = 0.048). A high HDRS score was the only predictor of apathy in PD [hazard ratio (HR) 1.043, p = 0.026].Conclusions: The risk of apathy is higher in men with progressive PD accompanied by disease-specific motor and non-motor symptoms. Depression during early-stage PD is a primary risk factor for apathy in PD.
topic Parkinson's disease
apathy
depression
executive function
cohort study
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.620762/full
work_keys_str_mv AT ruweiou evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT junyulin evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT kunchengliu evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT zhengjiang evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT qianqianwei evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT yanbinghou evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT lingyuzhang evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT beicao evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT bizhao evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT weisong evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
AT huifangshang evolutionofapathyinearlyparkinsonsdiseasea4yearsprospectivecohortstudy
_version_ 1724320125873553408